GRINT PAUL C 4
4 · Inhibikase Therapeutics, Inc. · Filed Jul 18, 2024
Insider Transaction Report
Form 4
GRINT PAUL C
Director
Transactions
- Award
Stock Option (right to buy)
2024-07-16+30,000→ 30,000 totalExercise: $1.54Exp: 2031-07-16→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The options will vest on the earlier of July 16, 2025 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date.